Digital inhalers can detect significant changes in physiologic and inhaler use metrics in the 14 days before COPD exacerbations.

Chronic rhinosinusitis with nasal polyps increases the likelihood of developing coexisting conditions, such as asthma, underscoring the need for more effective, comprehensive treatments.

Use of a pMDI with a holding chamber is noninferior to nebulization for delivering salbutamol in children with asthma exacerbations.

Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...

A 70-year-old man was taken to the emergency room due to sudden difficulty in breathing. The diagnostic result is 'Closed embolism'. A month ago, while lying in a hospital bed with a fracture in his ...

Objective Long-term azithromycin treatment effectively prevents acute exacerbations of chronic obstructive pulmonary disease ...

TUESDAY, July 1, 2025 (HealthDay News) -- Digital inhalers may help predict the occurrence of acute exacerbations of chronic obstructive pulmonary disease (COPD) for patients in an ambulatory setting, ...

TUESDAY, July 1, 2025 (HealthDay News) -- Digital inhalers may help predict the occurrence of acute exacerbations of chronic obstructive pulmonary disease (COPD) for patients in an ambulatory ...

Acute exacerbation of anti-Ha antibody-positive antisynthetase syndrome-associated interstitial lung disease: a case report By Li Y, Ke J, Huang S, Lin S, Lei S, Huang H, Lei L, Li Q, Wu Y and Duan M ...

This review aimed to assess the safety and efficacy of intravenous aminophylline in addition to standard first-line treatment with inhaled/nebulised Short-Acting Beta Agonist (SABA) and systemic ...

Introduction In patients with chronic obstructive pulmonary disease (COPD), the risk of certain cardiovascular (CV) events is increased by threefold to fivefold in the year following acute ...

Table 2 summarizes the influence of current drug treatments on acute asthma or COPD exacerbations, listing recent clinical trials and meta-analyses with the NNT to prevent one exacerbation.